Nurse practitioner's independent prescriptive authority and opioids abuse

Area of Science:

• Health Policy
• Pharmacology
• Public Health

Background:

• Legislative changes have expanded the prescribing authority of advanced practice professionals.
• The independent prescribing of Schedule II controlled substances by nurse practitioners is a recent development in healthcare policy.
• Understanding the impact of these policy changes on opioid use disorder is crucial.

Purpose of the Study:

• To investigate the impact of nurse practitioners independently prescribing Schedule II controlled substances.
• To determine the association between this legislative change and opioid misuse treatment admissions.
• To examine the relationship between independent prescribing authority and opioid-related mortality.

Main Methods:

• Analysis of legislative changes regarding nurse practitioner prescribing authority.
• Examination of treatment admission data for opioid misuse.
• Evaluation of opioid-related mortality data.
• Assessment of the moderating role of Mandatory Prescription Drug Monitoring Programs.

Main Results:

• Nurse practitioner independent prescribing of Schedule II substances was linked to increased treatment admissions for opioid misuse.
• Opioid-related mortality decreased under these conditions, but only when Mandatory Prescription Drug Monitoring Programs were implemented.
• The presence of Prescription Drug Monitoring Programs was a critical factor in mitigating negative outcomes.

Conclusions:

• Expanding nurse practitioner prescribing authority for Schedule II drugs can increase treatment seeking for opioid misuse.
• Policy interventions, such as Mandatory Prescription Drug Monitoring Programs, are essential to ensure patient safety and reduce opioid-related deaths.
• Integrating prescribing authority with robust monitoring systems is key for effective public health strategies.